The influence of recrystallized caffeine on water-swellable polymethacrylate mucoadhesive buccal films

AAPS PharmSciTech

Volumn 14, Issue 2, 2013, Pages 475-484

  Morales, Javier O ^a,b   Su, Rong ^c   McConville, Jason T ^a,d  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF CHILE   (Chile)

^c University of Bath   (United Kingdom)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

buccal films; caffeine; Eudragit ; mucoadhesive polymer; solvent casting

Indexed keywords

CAFFEINE; CARBOMER; EUDRAGIT RS; POLYCARBOPHIL; POLYMETHACRYLIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; KINETICS; MORPHOLOGY; MUCOADHESION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ACRYLIC RESINS; ADHESIVENESS; ADMINISTRATION, BUCCAL; CAFFEINE; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; KINETICS; MUCINS; POLYMERS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 84879088162     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9891-3     Document Type: Article

References (48)

1. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57(11):1666-91.
2. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery - a promising option for orally less efficient drugs. J Control Release. 2006;114(1):15-40.
3. Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011;77(2):187-99.
4. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 1998;1(1):15-30.
5. Repka MA, McGinity JW. Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. J Control Release. 2001;70(3):341-51.
6. Prodduturi S, Manek RV, Kolling WM, Stodghill SP, Repka MA. Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci. 2005;94(10):2232-45.
7. Thumma S, ElSohly MA, Zhang S, Gul W, Repka MA. Influence of plasticizers on the stability and release of a prodrug of [Delta]9-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices. Eur J Pharm Biopharm. 2008;70(2):605-14.
8. Aitken-Nichol C, Zhang F, McGinity JW. Hot melt extrusion of acrylic films. Pharm Res. 1996;13(5):804-8.
9. Perumal VA, Govender T, Lutchman D, Mackraj I. Investigating a new approach to film casting for enhanced drug content uniformity in polymeric films. Drug Dev Ind Pharm. 2008;34(10):1036-47.
10. Yang RK, Fuisz RC, Myers GL, Fuisz JM. Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom [internet]. 2003 [cited 2009 Nov 3]. Available from: http://www.freepatentsonline.com/y2003/0107149.html.
11. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94-107.
12. McQuinn RL, Benes L, Horriere F. Oral transmucosal delivery of melatonin. In: Ghosh TK, Pfister WR, editors. Drug delivery to the oral cavity: molecules to market. New York: Marcel Dekker Inc; 2005.
13. Wu X, Desai K-GH, Mallery SR, Holpuch AS, Phelps MP, Schwendeman SP. Mucoadhesive fenretinide patches for site-specific chemoprevention of oral cancer: enhancement of oral mucosal permeation of fenretinide by coincorporation of propylene glycol and menthol. Mol Pharm. 2012;9(4):937-45.
14. Desai K-G, Mallery S, Holpuch A, Schwendeman S. Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer. Pharm Res. 2011;28(10):2599-609.
15. Palem C, Gannu R, Doodipala N, Yamsani V, Yamsani M. Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization. Arch Pharm Res. 2011;34(10):1701-10.
16. Cilurzo F, Minghetti P, Selmin F, Casiraghi A, Montanari L. Polymethacrylate salts as new low-swellable mucoadhesive materials. J Control Release. 2003;88(1):43-53.
17. Perumal VA, Lutchman D, Mackraj I, Govender T. Formulation of monolayered films with drug and polymers of opposing solubilities. Int J Pharm. 2008;358(1-2):184-91.
18. Wong CF, Yuen KH, Peh KK. An in-vitro method for buccal adhesion studies: importance of instrument variables. Int J Pharm. 1999;180(1):47-57.
19. Mizrahi B, Domb AJ. Mucoadhesive polymers for delivery of drugs to the oral cavity. Recent Pat Drug Deliv Formul. 2008;2(2):108-19.
20. Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci. 2008;70(1):43-8.
21. Sawyer LC, Grubb DT, Meyers GF. Image formation in the microscope. Polymer microscopy. 3rd ed. New York: Springer; 2008. p. 67-129.
22. Parikh NH, Porter SC, Rohera BD. Tensile properties of free films cast from aqueous ethylcellulose dispersions. Pharm Res. 1993;10(6):810-5.
23. Okhamafe AO, York P. Stress crack resistance of some pigmented and unpigmented tablet film coating systems. J Pharm Pharmacol. 1985;37(7):449-54.
24. Weatherell JA, Robinson C, Rathbone MJ. The flow of saliva and its influence on the movement, deposition and removal of drugs administered to the oral cavity. In: Rathbone MJ, editor. Oral mucosal drug delivery. New York: Marcel Dekker Inc; 1996. p. 157-89.
25. Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20(6):64-74.
26. Higuchi T. Mechanism of sustained-action medication. The theoretical analysis of rate of solids drugs dispersed in solid matrices. J Pharm Sci. 1996;52:1145-9.
27. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25-35.
28. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123-33.
29. Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263-71.
30. Sawyer LC, Grubb DT, Meyers GF. Fundamentals of microscopy. Polymer microscopy. 3rd ed. New York: Springer; 2008. p. 27-66.
31. Derollez P, Correia NT, Danede F, Capet F, Affouard F, Lefebvre J, et al. Ab initio structure determination of the high-temperature phase of anhydrous caffeine by X-ray powder diffraction. Acta Crystallogr B Struct Sci. 2005;61(3):329-34.
32. Edwards HGM, Lawson E, de Matas M, Shields L, York P. Metamorphosis of caffeine hydrate and anhydrous caffeine. J Chem Soc Perkin Trans 2. 1997;(10):1985-90.
33. Chang RK, Peng Y, Trivedi N, Shukla AJ. Polymethacrylates. In: Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of pharmaceutical excipients. Grayslake, IL: Pharmaceutical Press, 2009. p. 525-33.
34. Evonik Industries. Sustained-release formulations. Eudragit Application Guidelines. 11th ed. Darmstadt: Evonik Rohm GmbH; 2009. p. 1-12.
35. Omari DM, Sallam A, Abd-Elbary A, El-Samaligy M. Lactic acid-induced modifications in films of Eudragit RL and RS aqueous dispersions. Int J Pharm. 2004;274(1-2):85-96.
36. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci. 1999;2(2):53-61.
37. Singh S, Jain S, Muthu M, Tiwari S, Tilak R. Preparation and evaluation of buccal bioadhesive films containing clotrimazole. AAPS PharmSciTech. 2008;9(2):660-7.
38. Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release. 1985;2:257-75.
39. Kinloch AJ. The science of adhesion: part 1 surface and interfacial aspects. J Mater Sci. 1980;15(9):2141-66.
40. Hench LL, Ethridge EC. Biomaterials: an interfacial approach. New York: Academic; 1982.
41. Horowitz MI. Gastrointestinal glycoproteins. Glycoconjugates. 1977;1:189.
42. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57(11):1556-68.
43. Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. Polymers for mucoadhesive drug delivery system: a current status. Drug Dev Ind Pharm. 2008;34(11):1246.
44. Schmidt W. Process for producing an administration or dosage form for drugs, reagents or other active ingredients. 1989.
45. Skalsky B, Petereit HU. Chemistry and application properties of polymethacrylate systems. In: McGinity JW, Felton LA, editors. Aqueous polymeric coatings for pharmaceutical dosage forms. 3rd ed. New York: Informa Healthcare; 2008. p. 237-77.
46. Leuenberger H, Bonny JD, Kolb M. Percolation effects in matrix-type controlled drug release systems. Int J Pharm. 1995;115(2):217-24.
47. Ritger PL, Peppas NA. A simple equation for description of solute release. I: Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5(1):23-36.
48. Llabot JM, Manzo RH, Allemandi DA. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. Int J Pharm. 2004;276(1-2):59-66.